For: | Colosimo S, Tomlinson JW. Bile acids as drivers and biomarkers of hepatocellular carcinoma. World J Hepatol 2022; 14(9): 1730-1738 [PMID: 36185719 DOI: 10.4254/wjh.v14.i9.1730] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v14/i9/1730.htm |
Number | Citing Articles |
1 |
Rachel M. Golonka, Beng San Yeoh, Piu Saha, Amira Gohara, Ramakumar Tummala, Stanislaw Stepkowski, Amit K. Tiwari, Bina Joe, Frank J. Gonzalez, Andrew T. Gewirtz, Matam Vijay-Kumar. Loss of toll-like receptor 5 potentiates spontaneous hepatocarcinogenesis in farnesoid X receptor–deficient mice. Hepatology Communications 2023; 7(6) doi: 10.1097/HC9.0000000000000166
|
2 |
Jayashi Rajapakse, Saroj Khatiwada, Anna Camille Akon, Kin Lam Yu, Sj Shen, Amany Zekry. Unveiling the complex relationship between gut microbiota and liver cancer: opportunities for novel therapeutic interventions. Gut Microbes 2023; 15(2) doi: 10.1080/19490976.2023.2240031
|
3 |
Sijia Dai, Jingfei Zhu, Xuqiong Chen, Liming Zheng, Xiaoping Li, Longgen Liu. Alteration of serum bile acid profiles of HBV-related hepatocellular carcinoma identified by LC–MS/MS. Journal of Cancer Research and Clinical Oncology 2024; 150(3) doi: 10.1007/s00432-024-05686-6
|
4 |
Annarosa Floreani, Daniela Gabbia, Sara De Martin. Current Perspectives on the Molecular and Clinical Relationships between Primary Biliary Cholangitis and Hepatocellular Carcinoma. International Journal of Molecular Sciences 2024; 25(4): 2194 doi: 10.3390/ijms25042194
|